ro.glp 1 CHARLES BARKLEY PARTNERS WITH RO AS GLP-1 CELEBRITY AMBASSADOR RO OFFERS ELI LILLY'S FOUNDAYO™,

GLP-1 is an incretin hormone that enhances insulin secretion in response to meals and promotes satiety

Healthcare providers evaluate individual risk factors, potential contraindications, and medication interactions to ensure safety and appropriateness

OZEMPIC also reduced the annual rate of change in eGFR (Figure 9), the incidence of a composite cardiovascular endpoint, consisting of non-fatal myocardial infarction (MI), non-fatal stroke, and cardiovascular death, and the incidence of all-cause death (Table 10 and Figure 8)

Primary endpoint: composite MACE (cardiovascular death, non-fatal myocardial infarction, non-fatal stroke)